3 Biotechs That Have Doubled Investors' Money in Less Than a Year Post author:Sam Post published:January 22, 2018 Post category:BioPharma Having a stock double in value is a good thing. Source: BioSpace You Might Also Like Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston July 17, 2017 Shire Snaps Up Rights to a Preclinical Autoimmune Candidate for Undisclosed Sum January 29, 2018 <b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco September 6, 2017
<b>GBSI</b> Biopolicy Summit 2017 Explores Newest Lab Automation, Digital Tools And Technologies Promising Improved Preclinical Research Reproducibility — October 16 In San Francisco September 6, 2017
